Zimmer Biomet Holdings, Inc. (ZBH) Stake Lowered by Bernzott Capital Advisors

Bernzott Capital Advisors cut its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 1.8% during the first quarter, Holdings Channel reports. The firm owned 26,979 shares of the medical equipment provider’s stock after selling 506 shares during the period. Bernzott Capital Advisors’ holdings in Zimmer Biomet Holdings were worth $3,294,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in ZBH. Stratos Wealth Partners LTD. boosted its stake in Zimmer Biomet Holdings by 19.3% in the first quarter. Stratos Wealth Partners LTD. now owns 17,782 shares of the medical equipment provider’s stock worth $2,171,000 after buying an additional 2,880 shares during the period. Tradition Capital Management LLC boosted its position in shares of Zimmer Biomet Holdings by 14.4% in the first quarter. Tradition Capital Management LLC now owns 24,565 shares of the medical equipment provider’s stock valued at $2,999,000 after buying an additional 3,090 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Zimmer Biomet Holdings by 8.5% in the first quarter. Wellington Management Group LLP now owns 30,549 shares of the medical equipment provider’s stock valued at $3,731,000 after buying an additional 2,396 shares during the last quarter. Gofen & Glossberg LLC IL boosted its position in shares of Zimmer Biomet Holdings by 7.8% in the first quarter. Gofen & Glossberg LLC IL now owns 5,899 shares of the medical equipment provider’s stock valued at $720,000 after buying an additional 426 shares during the last quarter. Finally, United Services Automobile Association boosted its position in shares of Zimmer Biomet Holdings by 0.4% in the first quarter. United Services Automobile Association now owns 282,268 shares of the medical equipment provider’s stock valued at $34,468,000 after buying an additional 1,098 shares during the last quarter. Institutional investors own 84.34% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (ZBH) opened at 129.06 on Tuesday. The firm has a market capitalization of $26.02 billion, a price-to-earnings ratio of 52.83 and a beta of 1.23. The firm has a 50-day moving average price of $121.37 and a 200 day moving average price of $116.68. Zimmer Biomet Holdings, Inc. has a one year low of $95.63 and a one year high of $133.21.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its earnings results on Thursday, April 27th. The medical equipment provider reported $2.13 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.11 by $0.02. The business had revenue of $1.98 billion during the quarter, compared to the consensus estimate of $1.96 billion. Zimmer Biomet Holdings had a return on equity of 16.80% and a net margin of 6.36%. The company’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the prior year, the business posted $2.00 EPS. Equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.54 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 23rd will be paid a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date of this dividend is Wednesday, June 21st. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is 39.67%.

COPYRIGHT VIOLATION NOTICE: “Zimmer Biomet Holdings, Inc. (ZBH) Stake Lowered by Bernzott Capital Advisors” was first posted by sleekmoney and is owned by of sleekmoney. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://sleekmoney.com/zimmer-biomet-holdings-inc-zbh-stake-lowered-by-bernzott-capital-advisors/1942651.html.

ZBH has been the subject of several research analyst reports. Canaccord Genuity restated a “buy” rating on shares of Zimmer Biomet Holdings in a research note on Friday, April 28th. Oppenheimer Holdings, Inc. set a $132.00 price objective on Zimmer Biomet Holdings and gave the stock a “buy” rating in a research note on Friday, April 28th. Royal Bank Of Canada restated a “buy” rating and issued a $133.00 price objective on shares of Zimmer Biomet Holdings in a research note on Tuesday, March 14th. ValuEngine cut Zimmer Biomet Holdings from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Finally, Wells Fargo & Company cut Zimmer Biomet Holdings from an “outperform” rating to a “market perform” rating in a research note on Friday, April 28th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $137.00.

In other news, insider Sang Yi sold 17,731 shares of the stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $124.56, for a total transaction of $2,208,573.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider David C. Dvorak sold 87,331 shares of the stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $116.47, for a total value of $10,171,441.57. Following the transaction, the insider now directly owns 381,886 shares of the company’s stock, valued at $44,478,262.42. The disclosure for this sale can be found here. Over the last three months, insiders have sold 111,262 shares of company stock valued at $13,103,927. Company insiders own 1.07% of the company’s stock.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/zimmer-biomet-holdings-inc-zbh-stake-lowered-by-bernzott-capital-advisors/1942651.html

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *